SCHEME 4
131.3, 129.8, 128.8, 127.8, 126.6, 126.5, 125.6, 38.5. IR (KBr,
cm-1): 3436, 1658, 1596, 1466. CI(methane)-MS; full MS, m/z
(relative intensity) 237 (100) [M + H]+, 265 [M + C2H5]+, 277
[M + C3H5]+; MS2(237,w5,EV1.5), m/z 235, 220, 208, 194, 179,
167, 134, 105. Anal. Calcd for C15H12N2O: C, 76.25; H, 5.12; N,
11.86. Found: C, 76.31; H, 5.14; N, 11.90.
2-(2-Oxo-2-phenylethylamino)benzamide (6). Anthranilamide
(5) (1 g, 7.3 mmol) was dissolved in dimethylformamide (10 mL),
and potassium carbonate (1 g, 7.14 mmol) was added. The reaction
mixture was heated to 90 °C and stirred for 2 h. Then the solution
was cooled to 20 °C, and phenacyl bromide (1.45 g, 7.3 mmol)
was added. After being stirred for 180 min, the solution was poured
into cold water. The precipitated solid was collected by filtration,
washed with water, and dried, yielding 1 g (54%) of 6. The product
was crystallized from ethanol for analytical purposes: mp 175-
MS) technique with quadrupole ion trap mass analyzer and methane
as the CI reagent gas. Thin-layer chromatography was performed
on Sil G/UV254 plates with UV detection at 254 nm. NMR spectra
were measured with a spectrometer operating at 300.13 MHz (1H)
and 75.47 MHz (13C). The compounds were dissolved in DMSO-
d6 and measured at 300 K. Melting points were determined on a
Boetius stage and were not corrected.
1
177 °C. H NMR (DMSO-d6, 300 MHz) δ 8.73 (1H, bs), 8.12-
8.07 (2H, m), 7.81 (1H, bs), 7.69 (1H, tt, J ) 7.3, 1.3 Hz), 7.63
(1H, dd, J ) 7.9, 1.5 Hz), 7.57 (2H, t, J ) 7.5 Hz), 7.32-7.25
(1H, m), 7.15 (1H, bs), 6.76 (1H, d, J ) 8.4 Hz), 6.58 (1H, t,
J ) 7.5 Hz), 4.80 (2H, s); 13C NMR (DMSO-d6, 75 MHz) δ
195.5, 171.3, 148.7, 135.0, 133.6, 132.4, 128.9, 128.8, 127.8, 114.5,
114.3, 112.0, 49.7. IR (KBr, cm-1): 3367, 3236, 1731, 1643, 1632,
1618, 1513. CI(methane)-MS; full MS, m/z (relative intensity)
255 (40) [M + H]+, 283 [M + C2H5]+, 295 [M + C3H5]+,
238 (100) [M + H - NH3]+, 194 [C6H5NHCHCH C6H5]+; MS2-
(255,w5,EV1), m/z 238, 220, 212, 194, 149, 132, 120. Anal. Calcd
for C15H14N2O2: C, 70.85; H, 5.55; N, 11.02. Found: C, 70.61;
H, 5.55; N, 10.98.
3-Amino-2-phenyl-4(1H)-quinolinone (7a). Method A: An-
thranilamide 2a (2 g, 7.87 mmol) was mixed with polyphos-
phoric acid (20 g), and the reaction mixture was heated to 150 °C.
After heating for 1.5 h at this temperature, the starting material
was no longer observed in TLC (ethyl acetate). The reaction mix-
ture was poured onto sodium carbonate (20 g), and after foaming
had stopped, water (300 mL) was added. After 30 min of stirring,
a solid product was filtered off and washed with water. The
yield of the product 7a was 1.8 g (97%): mp 250-253 °C. Using
HPLC, we found its purity to be 98%. Crystallization was car-
ried out for analytical purposes: mp 256-259 °C (acetone) (lit:10
mp 243-245 °C, aqueous ethanol). 1H NMR (DMSO-d6, 300
MHz) δ 11.44 (1H, s), 8.12 (1H, d, J ) 8.2 Hz), 7.75-7.70 (2H,
m), 7.65-7.47 (5H, m), 7.24-7.17 (1H, m), 4.22 (2H, s); 13C NMR
(DMSO-d6, 75 MHz) δ 169.7, 137.6, 133.7, 129.8, 129.7, 129.1,
128.9, 128.8, 127.9, 124.6, 121.3, 120.6, 118.1. IR (KBr, cm-1):
3346, 1633, 1570, 1493. CI(methane)-MS; full MS, m/z (relative
intensity) 237 (100) [M + H]+, 265 [M + C2H5]+, 277 [M +
C3H5]+, 220 [M + H - NH3]+; MS2(237,w5,EV1.5), m/z 235, 220,
208, 206, 190, 180, 165, 152, 132, 104. Anal. Calcd for
C15H12N2O: C, 76.25; H, 5.12; N, 11.86. Found: C, 76.00; H, 5.14;
N, 11.80.
Method B: Diazepine 4a (250 mg, 1.058 mmol) was stirred with
polyphosphoric acid (5 g) at 150 °C. After an hour at this
temperature, the starting material could no longer be observed in
TLC (ethyl acetate). The reaction mixture was poured over solid
sodium carbonate (5 g). After foaming had stopped, water (60 mL)
was added. After 30 min of stirring, the solid product was filtered
off and washed with water. The yield of the product 7a was 225
mg (90%): mp 256-259 °C.
Method C: Oxazole derivative 3a (336 mg, 1.42 mmol) was
stirred with polyphosphoric acid (3.4 g), and the reaction mixture
was heated to 170 °C for 2 h. The reaction mixture was poured
onto sodium carbonate (5 g), and after foaming had stopped, water
(30 mL) was added. After 30 min of stirring, the solid product was
filtered off and washed with water. The yield of the product 7a
was 306 mg (91%). mp 254-258 °C (acetone).
2-Amino-N-(2-oxo-2-phenylethyl)benzamide (2a). 2-Amino-
acetophenone hydrochloride (1a) (1 g, 5.83 mmol) was dissolved
in water (20 mL). Isatoic anhydride (1.0 g, 6.14 mmol) and sodium
carbonate (0.38 g, 3.59 mmol) were added. After being stirred for
5 min, the reaction mixture was gradually heated to 80 °C over 30
min. At 30 °C the mixture began to foam. On reaching 80 °C it
was stirred for a further 10 min. After this, the solid phase was
filtered off and washed with a solution of sodium carbonate and
water to neutral pH. The solid was dried in vacuo to yield 1.38 g
(93%) of compound 2a. The product was used for the next synthetic
step without purification, but for analytical purposes it was
crystallized: mp 128-130 °C (acetone). 1H NMR (DMSO-d6, 300
MHz) δ 8.55 (1H, t, J ) 5.5 Hz), 8.06-8.01 (2H, m), 7.68 (1H, tt,
J ) 7.5, 1.3 Hz), 7.61-7.52 (3H, m), 7.20-7.13 (1H, m), 6.71
(1H, d, J ) 8.2 Hz), 6.58-6.51 (1H, m), 6.41 (2H, bs), 4.71
(2H, d, J ) 5.5 Hz); 13C NMR (DMSO-d6, 75 MHz) δ 195.6,
169.1, 149.7, 135.1, 133.4, 131.9, 128.8, 128.1, 127.8, 116.4, 114.6,
114.0, 46.1. IR (KBr, cm-1): 3449, 3344, 3331, 1697, 1633, 1534.
CI(methane)-MS; full MS, m/z (relative intensity) 255 (30) [M +
H]+, 283 [M + C2H5]+, 295 [M + C3H5]+, 237 [M + H - H2O]+,
120 (100) [C6H4CO(NH2)]+; MS2(255,w5,EV1), m/z 237, 235, 224,
194, 149, 120. Anal. Calcd for C15H14N2O2: C, 70.85; H, 5.55; N,
11.02. Found: C, 70.53; H, 5.53; N, 11.00.
2-(5-Phenyl-2-oxazolyl)phenylamine (3a). A mixture of an-
thranilamide 2a (280 mg, 1.1 mmol) and sulfuric acid (3 mL) was
heated to 50 °C for 3 h, and the reaction mixture was subsequently
poured into water and neutralized with sodium carbonate. The
precipitated product was filtered off, dried, and crystallized from
methanol: 230 mg (88%), mp 130-131.5 °C (lit:13 mp 128 °C).
1H NMR (DMSO-d6, 300 MHz) δ 7.91 (1H, dd, J ) 8.1, 1.5 Hz),
7.86-7.82 (3H, m), 7.54-7.47 (2H, m), 7.38 (1H, tt, J ) 7.3, 1.3
Hz), 7.24-7.17 (1H, m), 6.93-6.73 (2H, bs), 6.86 (1H, dd, J )
8.3, 0.8 Hz), 6.70-6.64 (1H, m); 13C NMR (DMSO-d6, 75 MHz)
δ 160.7, 148.6, 147.3, 131.3, 129.1, 128.4, 127.4, 127.0, 123.9,
123.1, 115.8, 115.4, 107.5. IR (KBr, cm-1): 3462, 3360, 3339,
1603, 1537, 1489, 1446. CI(methane)-MS; full MS, m/z (relative
intensity) 237 (100) [M + H]+, 265 [M + C2H5]+, 277 [M +
C3H5]+; MS2(237,w5,EV1.5), m/z 236, 219, 209, 180, 131. Anal.
Calcd for C15H12N2O: C, 76.25; H, 5.12; N, 11.86. Found: C,
76.20; H, 5.17; N, 11.95.
2-Phenyl-3H-benzo[e][1,4]diazepin-5-one (4a). Anthranilamide
2a (0.5 g, 1.97 mmol) was dissolved in xylene (5 mL), and the
reaction mixture was heated under reflux for 4 h. The organic
solution was evaporated to dryness, and the residue was purified
by column chromatography on silica gel with toluene as eluent.
One main product was isolated. This product was crystallized from
tetrahydrofuran to give compound 4a: 260 mg (56%), mp 132-
135 °C (lit:8 mp 173-175 °C). 1H NMR (DMSO-d6, 300 MHz) δ
8.56 (1H, t, J ) 5.9 Hz), 8.10-8.06 (2H, m), 7.89-7.84 (1H, m),
7.66-7.51 (4H, m), 7.40-7.32 (2H, m), 3.96 (2H, d, J ) 5.9 Hz);
13C NMR (DMSO-d6, 75 MHz) δ 167.9, 167.4, 146.4, 136.2, 131.6,
Method D: Anthranilamide 6 (250 mg, 0.983 mmol) was stirred
with polyphosphoric acid (5 g), and the reaction mixture was heated
to 140 °C for 2 h. After the starting material could no longer be
J. Org. Chem, Vol. 71, No. 2, 2006 821